Hanmi Fine Chemical Acquires Patent for Thiazole Compound.

Published: 2001-10-18 06:57:00

Updated: 2001-10-18 06:57:00

Hanmi Pharmaceutical Company announced on the 11th that Hanmi Fine Chemical, an affiliate company, has acquired a patent in the United States for a Thiazole compound and a process for it that sharply reduces manufacturing costs and simplifies the compound processing of antibiotics.

Thiazole is...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK